Editas Medicine (EDIT) Revenue Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) Revenue Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.56% |
| Jun 30, 2025 | -19.75% |
| Mar 31, 2025 | -4.03% |
| Dec 31, 2024 | 20.03% |
| Sep 30, 2024 | -56.35% |
| Jun 30, 2024 | -26.12% |
| Mar 31, 2024 | -11.32% |
| Dec 31, 2023 | 57.89% |
| Sep 30, 2023 | -18.14% |
| Jun 30, 2023 | -17.10% |
| Mar 31, 2023 | 20.19% |
| Dec 31, 2022 | -5.78% |
| Sep 30, 2022 | -66.57% |
| Jun 30, 2022 | 10.98% |
| Mar 31, 2022 | 58.26% |
| Dec 31, 2021 | 69.24% |
| Sep 30, 2021 | 45.14% |
| Jun 30, 2021 | -35.47% |
| Mar 31, 2021 | 51.85% |
| Dec 31, 2020 | 70.52% |